ProQR Therapeutics (PRQR) Convertible Debt (2013)
ProQR Therapeutics (PRQR) posted Convertible Debt of $3.4 million for Q4 2013.
ProQR Therapeutics (PRQR) Convertible Debt (2013) Analysis & Trends
ProQR Therapeutics has reported Convertible Debt for 1 years, with the latest figure at $3.4 million in Q4 2013.
- Quarterly Convertible Debt changed N/A year-over-year to $3.4 million in Q4 2013, while the trailing twelve-month figure through Dec 2013 was $3.4 million (changed N/A YoY) and the FY2013 annual result came in at $3.3 million, changed N/A from the prior year.
- Convertible Debt held at $3.4 million in Q4 2013 per PRQR's latest filing.
- Over five years, Convertible Debt peaked at $3.4 million in Q4 2013 and troughed at $3.4 million in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | ProQR Therapeutics | 206.80 Mn | 111.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 3.42 Mn |